ArticleCancer research communications2024

Anti-Vα24Jα18 TCR Antibody Tunes iNKT Cell Responses to Target and Kill CD1d-negative Tumors in an FcγRII (CD32)-dependent Manner.

Mariko Takami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.